The injection process involves using an IV drip to deliver the 'RNP Complex' of the EBT-002 gene therapy agent to cells throughout the body via blood vessels.
Throughout the process, various negative reactions of the human body will occur, such as pain, numbness, itching, fever, chills, high fever, coma, and other abnormal phenomena.
The medical staff at Lian City People's Hospital were fully prepared to provide emergency care to the three clinical trial participants should any unexpected situations arise.
Time passed by, and as the EBT-002 gene therapy agent began to flow, a fierce battle was raging at the cellular and genetic levels.
In just over ten minutes, the EBT-002 gene therapy agent was completely injected.
The next injections were all routine solutions like glucose to replenish the cells' energy consumption.
Netizens patiently awaited the latest results. Although some left midway, they would occasionally return to check for the latest updates.
As for the domestic and foreign journalists on site, they were rather unlucky; they had to stay on site and wait for the latest results.
The whole process was actually quite boring.
Aside from fever, chills, and occasional coughing, none of the three individuals experienced any special circumstances requiring emergency treatment.
Time passed by little by little, and before we knew it, it was the third day.
On this day, after a physical examination in the morning, they will receive a second injection of the EBT-002 gene therapy drug.
As for whether a third injection is necessary?
Whether a third injection of EBT-002 gene therapy drug is needed depends on the test results after the second injection.
After all, theoretically, two injections should be enough to completely eliminate the AIDS virus from the body.
If the test shows that there is no AIDS virus in the body, then it is possible to stop injecting the third bottle of EBT-002 gene therapy drug.
Of course, if you have the money and want to continue getting injections, that's fine too. After all, the adverse reactions from the injections are acceptable, and more injections provide an extra layer of safety.
However, the only headache is the cost. Xingtu Gene Company quotes 10,000 Xia Yuan per bottle for EBT-002 gene therapy.
The cost of three bottles of medicine, plus the money for physical examinations, genetic sequencing matching, and hospitalization, will definitely start at 40,000 yuan for the whole process.
Of course, if only two vials of this EBT-002 gene therapy drug are needed, the price would start at around 30,000 yuan.
Furthermore, due to medical insurance reimbursement, the actual cost will definitely not be that much.
After all, with such miraculous effects, it's easy to imagine that this drug would be included in the list of drugs covered by national health insurance in various countries, and ultimately, with health insurance reimbursement, only a portion of the cost would need to be paid.
But netizens didn't care about all that, nor did they consider how much they would actually have to pay after medical insurance reimbursement.
At this point, seeing the extremely high price of EBT-002 gene therapy drug, some people will naturally think it's expensive.
Some people believe that Xingtu Gene Company is simply robbing people by charging 10,000 Xia Yuan for a single bottle of EBT-002 gene therapy drug.
After all, a bottle of EBT-002 gene therapy drug is priced at 10,000 Xia Yuan, which does seem outrageous.
Therefore, they questioned the reasonableness of the price and believed that Lin Feng was a bloodsucker.
In response, Xingtu Gene Company provided a rough report on its expenditures.
This rough report on expenditures also revealed the terrifying rate at Xingtu Gene Company was burning through cash.
The 20 billion Xia Yuan and 3.2 billion US dollars allocated for the construction of gene research and development laboratories are particularly glaring.
Following that, the other research and development expenditures were also staggering, demonstrating Xingtu Gene Company's determination to burn money on research and development.
Finally, Lin Feng also posted on Weibo and Twitter that Xingtu Gene Company will not distribute any of its profits as dividends over the next ten years.
The parent company, Xingtu Technology, will not voluntarily withdraw money from its Xingtu Gene Company.
Lin Feng stated that all the money earned by Xingtu Gene Company within the next ten years will be used to explore the mysteries of human and universal genes and to solve human health problems!
Faced with Lin Feng's words, those who thought the EBT-002 gene therapy drug was too expensive also shut their mouths.
After all, Lin Feng claimed that he would not distribute dividends for ten years, and that all the money he earned in those ten years would be invested in scientific research and development.
This is to accelerate scientific research and development and solve human diseases. What do you mean by calling Lin Feng a vampire now?
Moreover, looking around the world, which company or boss would dare to give up such a large amount of profit and money as Lin Feng?
But Lin Feng Lam did it. Under such circumstances, it would be unreasonable to criticize Xingtu Gene Company for selling expensive drugs or to call Lin Feng a bloodsucker.
Of course, there will be people who criticize it, and that's something that can't be stopped, regardless of whether the EBT-002 gene therapy drug sells for ten thousand yuan or two or three thousand yuan.
After all, the manufacturing cost of EBT-002 gene therapy drug is indeed there; the average cost of one bottle is several hundred yuan.
After all, it uses a chemical synthesis method, which not only requires expensive equipment and extremely high raw material requirements, but also involves hundreds of procedures in the entire manufacturing process, making it incredibly complicated.
Finally, it must be injected immediately after production, otherwise its efficacy will gradually decrease over time.
All these drawbacks combined mean that this product won't be much cheaper, especially considering the tax, R&D, and other costs.
The final selling price must be over 2,000 yuan, otherwise it will be sold at a bargain price. And once the price exceeds 2,000 yuan, it will naturally be met with criticism.
But since they're going to be criticized anyway, Xingtu Gene Company naturally has to offer a higher price to earn more profit, so they can use the money for scientific research and development instead of selling it at a bargain price.
Of course, 10,000 yuan a bottle is really not expensive.
Don't they know about Hepatitis C treatment drug developed by the American Empire Gilead Company Sofosbuvir?
This drug costs 7,820 Xia Yuan per pill in the American Empire. The movie "Dying to Survive" tells the story of this extremely expensive drug!
Great Xia is a country with a high prevalence of hepatitis, with approximately 45 million Hepatitis C patients nationwide. One can imagine just how much money Gilead Company makes.
Therefore, compared to the American Empire pharmaceutical companies, Xingtu Gene Company is practically an angel.
After all, using the EBT-002 gene therapy drug can not only directly resolve the AIDS virus, but also provide immunity in the future.
This is something that Xingtu Technology naturally wants to promote extensively, and the effect of such extensive promotion is quite good.
The more you compare, the more reasonable the price of Xingtu Gene Company's EBT-002 gene therapy drug becomes, given Gilead Company's example.
Therefore, most people accept and tacitly acknowledge the reasonableness of the extremely high price of EBT-002 gene therapy drug.
Time continued to pass, and several days went by in the blink of an eye. It was the 7th day of the clinical trial of the EBT-002 gene therapy drug.
On this day, the three clinical trial participants underwent a unified physical examination early in the morning, followed by a physical examination in the afternoon.
Xingtu Gene Company and Great Xia Medical Institution jointly announced the great success of the clinical trial of the EBT-002 gene therapy agent in three cases worldwide.
After a physical examination on the morning of the seventh day, it was found that the AIDS virus was no longer present in the bodies of the three AIDS patients!